News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
1,026 Results
Type
Article (81)
Company Profile (2)
Press Release (943)
Section
Business (309)
Career Advice (1)
Deals (86)
Drug Development (99)
FDA (29)
Job Trends (33)
News (514)
Policy (48)
Tag
Academia (4)
Alliances (57)
Alzheimer's disease (1)
Antibody-drug conjugate (ADC) (1)
Approvals (28)
Artificial intelligence (1)
Automation (2)
Bankruptcy (1)
Best Places to Work (27)
Biotechnology (1)
Brain cancer (1)
Breast cancer (2)
Cancer (9)
Career advice (1)
Cell therapy (4)
Clinical research (90)
Collaboration (4)
Complete response letters (1)
COVID-19 (9)
C-suite (3)
Data (6)
Diagnostics (8)
Earnings (105)
Events (151)
FDA (30)
Funding (2)
Gene therapy (1)
GLP-1 (7)
Government (9)
Healthcare (61)
Infectious disease (9)
IPO (21)
Job creations (6)
Job search strategy (1)
Layoffs (1)
Legal (7)
Lymphoma (1)
Manufacturing (3)
MASH (1)
Medical device (19)
Medtech (19)
Mergers & acquisitions (66)
Metabolic disorders (1)
Neurodegenerative disease (3)
Neuroscience (13)
NextGen: Class of 2026 (20)
Non-profit (5)
Opinion (1)
Parkinson's disease (9)
Patient recruitment (1)
People (125)
Phase 1 (36)
Phase 2 (53)
Phase 3 (36)
Pipeline (9)
Postmarket research (3)
Preclinical (2)
Rare diseases (2)
Real estate (12)
Regulatory (36)
Research institute (2)
Startups (3)
Stomach cancer (1)
Vaccines (2)
Date
Last 30 days (2)
Last 365 days (37)
2026 (7)
2025 (38)
2024 (63)
2023 (50)
2022 (107)
2021 (148)
2020 (98)
2019 (79)
2018 (44)
2017 (29)
2016 (30)
2015 (24)
2014 (21)
2013 (25)
2012 (52)
2011 (32)
2010 (34)
Location
Africa (12)
Arizona (2)
Asia (86)
Australia (24)
California (46)
Canada (3)
Europe (97)
Louisiana (1)
Massachusetts (3)
New Jersey (3)
New York (5)
Northern California (21)
Ohio (1)
South America (1)
Southern California (24)
United States (59)
Washington State (1)
Wisconsin (1)
1,026 Results for "aspen neuroscience.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Aspen’s $115M Series C Opens Doors to Late-Stage Development for Parkinson’s Program
Aspen is now also considering the possibility of an initial public offering next year in an effort to bring its cell therapy to the market.
November 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Aspen Neuroscience Announces $115 Million Series C Financing to Accelerate Personalized Cell Therapy Programs
November 21, 2025
·
4 min read
Press Releases
Aspen Neuroscience Completes Phase 1/2a ASPIRO Trial Cohort Three Dosing and State-of-the-Art Manufacturing Expansion, Paving the Way for Developing Transformative Therapies for Patients
January 9, 2026
·
4 min read
Press Releases
Aspen Neuroscience Appoints Chief Commercial Officer Lisa Johnson-Pratt, M.D. and Welcomes Revati Shreeniwas, M.D., FCCP as Chief Medical Officer to Accelerate Late‑Stage Development and Commercial Readiness
January 8, 2026
·
4 min read
Press Releases
Aspen Neuroscience Initiates Cohort 3 in ASPIRO Phase 1/2a Trial, Highlighting Commercial Formulation of ANPD001 and Its Transformative Potential for Parkinson’s Disease
September 26, 2025
·
4 min read
Press Releases
Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer
May 1, 2025
·
2 min read
Press Releases
Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting
June 9, 2025
·
2 min read
Press Releases
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 6, 2025
·
3 min read
Press Releases
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
April 25, 2025
·
8 min read
Press Releases
Aspen Neuroscience to Present at American Society of Gene & Cell Therapy (ASGCT) Annual Meeting
May 14, 2025
·
2 min read
1 of 103
Next
